News
Scientists have studied a new target for antibiotics in the greatest detail yet—in the fight against antibiotic resistance.
Industrial animal agriculture has relied extensively on the use of an antibiotic unused in human medicine, but new research ...
Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the United States Patent and Trademark ...
Wockhardt is advancing Zaynich, a novel antibiotic combination, targeting drug-resistant infections, with plans for regulatory submissions in the US and India. The company is exploring out-licensing ...
1d
Nigerian CommunicationWeek on MSNUdensi, Nigerian Scientist Warns of Antibiotic ResistanceDr. Chukwuma Great Udensi, U.S.-based Nigerian microbiologist, has raised the alarm over the rising threat of antibiotic resistance (ABR) in Nigeria, warning that it could severely impact the nation’s ...
Gram-negative bacteria develop resistance to commonly prescribed antibiotics through ... Antibiotic treatment guidelines consistently recommended empiric therapy upon patient presentation ...
The Nation Newspaper Nigerian scientist raises alarm over antibiotic resistance, advocates microbiome innovation ...
Dr. Jennifer Schneider discusses Centauri Therapeutics' novel approach to combating Gram-negative infections, its first ...
Small, hydrophilic molecules, including most important antibiotics in clinical use, cross the Gram-negative outer membrane through the water-filled channels provided by porins. We have determined the ...
Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results